Latest Articles

Side Effect Management Managing Adverse Events in the Era of Immunotherapy

Managing Adverse Events in the Era of Immunotherapy

The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.

Prostate Cancer Emerging Therapies for Prostate Cancer

Emerging Therapies for Prostate Cancer

New diagnostic and therapeutic tools are in development to inform the management of advanced and metastatic disease.

Bladder Cancer Muscle-Invasive Bladder Cancer: The Evolving Treatment Landscape

Muscle-Invasive Bladder Cancer: The Evolving Treatment Landscape

Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.

Renal Cell Carcinoma Multidisciplinary Models for Treating Renal Cell Carcinoma

Multidisciplinary Models for Treating Renal Cell Carcinoma

A shift toward multidisciplinary care is inevitable for the treatment of locally advanced and metastatic RCC.

Lung Cancer Exercise: A Growing Role in Lung Cancer Prevention, Treatment, and Survival

Exercise: A Growing Role in Lung Cancer Prevention, Treatment, and Survival

Regular exercise can help patients with cancer deal with issues related to weight gain during treatment.

General Oncology Healthful Lifestyles and Cancer: Much More Than A Single Behavior

Healthful Lifestyles and Cancer: Much More Than A Single Behavior

A recent study is the first to demonstrate the cumulative effect of a large number of lifestyle behaviors.

Skin Cancer Can Vismodegib Induce Melanoma in Patients Treated for Basal Cell Carcinoma?

Can Vismodegib Induce Melanoma in Patients Treated for Basal Cell Carcinoma?

Two cases raise the question of whether abnormal activation of the hedgehog signaling pathway can lead to a protective effect on melanomas.

General Oncology Cancer Immunosurveillance Comes of Age

Cancer Immunosurveillance Comes of Age

As oncologists learn to target the immune response to "self and non-self," a delicate therapy balance will eventually be achieved with predictable outcomes, benefits, and toxicity in the fight against cancer.

Chronic Myeloid Leukemia Chronic Myeloid Leukemia: Choosing A TKI

Chronic Myeloid Leukemia: Choosing A TKI

Clinical trial data regarding deep molecular response outcomes suggest that dasatinib and nilotinib are superior to the first-generation TKI, imatinib.

Gastrointestinal Cancers Periodontal Disease and Gastric Cancer Risk: An Interview With Dr Yihong Li

Periodontal Disease and Gastric Cancer Risk: An Interview With Dr Yihong Li

Cancer Therapy Advisor interviewed Dr Li about her research into the relationship between periodontal disease and gastric cancer.

Prostate Cancer Prostate Cancer: Hypofractionated Radiotherapy's Role in Post-operative Settings

Prostate Cancer: Hypofractionated Radiotherapy's Role in Post-operative Settings

Hypofractionated radiotherapy's role in postoperative settings remains unclear and awaits outcomes from ongoing studies.

Hematologic Cancers Managing Tumor Lysis Syndrome — In the Clinic

Managing Tumor Lysis Syndrome — In the Clinic

TLS considered an emergency, so it's crucial to initiate therapy as soon as possible.

General Oncology AI: Inroads Into Clinical Oncology

AI: Inroads Into Clinical Oncology

Novel algorithms may be able to diagnose and plan cancer treatments more effectively than humans, but it's unclear if and when artificial intelligence will be integrated into clinical practice.

Multiple Myeloma Reasons for MGUS Progression to Myeloma Remain Unclear

Reasons for MGUS Progression to Myeloma Remain Unclear

Studying how MGUS and myeloma clones change over time might yield new insights into myeloma's molecular heterogeneity.

Lung Cancer Lung Cancer: FDA Collaboration Highlights Real-world Immunotherapy Treatment Patterns

Lung Cancer: FDA Collaboration Highlights Real-world Immunotherapy Treatment Patterns

Study findings suggest that some clinicians are using immunotherapies in the types of patients not included in clinical trials.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs